Neuralink receives FDA clearance to begin human trials of its brain-computer interface
in December, more than 1,500 animals had been killed in the development of the Neuralink BCI since 2018. The US Department of Agriculture's Inspector General hasThe FDA's reticence was also born from concerns about the design and function of the interface when implanted in humans.
"The agency’s major safety concerns involved the device’s lithium battery; the potential for the implant’s tiny wires to migrate to other areas of the brain; and questions over whether and how the device can be removed without damaging brain tissue," current and former Neuralink employees toldGreat deals on consumer electronics delivered straight to your inbox, curated by Engadget’s editorial team.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Elon Musk’s Neuralink gets FDA approval for human test of brain implantsNeuralink is developing a brain implant it hopes will help paralyzed people walk again and cure other neurological ailments.
Lire la suite »
Elon Musk’s Neuralink Cleared By FDA for In-Human StudiesDespite a rocky past with federal officials and an initial rejection in March from the FDA, Elon Musk’s brain-chip company Neuralink shared on Twitter that it has received FDA approval to launch its first in-human clinical study.
Lire la suite »
Elon Musk's Neuralink gets FDA approval for study of brain implants in humansElon Musk's brain-implant company Neuralink on Thursday said it had received the U.S. Food and Drug Administration's (FDA) approval to launch its first-in-human clinical study.
Lire la suite »
The FDA will apparently let Elon Musk put a computer in a human’s brainRecruitment for Neuralink’s trial isn’t open yet.
Lire la suite »
FDA Approves Buprenorphine Injection for Opioid Use DisorderThe FDA has approved extended-release injection buprenorphine (Brixadi, Braeburn Inc) for the treatment of moderate to severe opioid use disorder.
Lire la suite »
TransCon PTH Nears US Approval for Hypoparathyroidism?Palopegteriparatide is a potential long-term therapy for adults with hypoparathyroidism, new findings suggest.
Lire la suite »